The National Institute for Clinical Excellence (NICE) approved
today the use of of Alimta for the treatment of mesothelioma across
the UK. After almost three years of
waiting, UK sufferers of mesothelioma will be able to claim
Alimta on prescription. Previously, it was
only available to patients in Scotland, in parts of the north
of England or in connection with clinical trials.
Andrew Morgan, partner in the
Asbestos Claims Department of Field Fisher
Waterhouse, comment: "This comes as an enormous relief to
people who are affected by mesothelioma, although
for some sufferers it has come too late. Even so, eligibility is
still limited and there will still be mesothelioma
sufferers for whom Alimta is clinically indicated who cannot
get the drug on the NHS. They should get advice from a specialist
mesothelioma lawyer as it may be possible to pay for this
treatment by making a claim for compensation."
For further information, please contact Andrew Morgan, Rodney
Nelson-Jones or Peter Williams on
020 7861 4000.